Human papillomavirus type 6 (HPV-6)

Human papillomavirus type 6 is a low-risk genotype within the human papillomavirus family. It is a small, non-enveloped double-stranded DNA virus that infects cutaneous and mucosal epithelial cells. HPV type 6 is most commonly associated with benign conditions such as genital warts (condyloma acuminata) and recurrent respiratory papillomatosis but does not cause cancer. The viral genome encodes early proteins involved in replication and late structural proteins such as L1 and L2. Prophylactic vaccines containing recombinant L1 protein from this genotype are used to prevent infection but do not treat established disease[2][3][4]. Note on correctness ("is_incorrect"): "Human papillomavirus type 6" refers to an entire virus species rather than a specific molecular target like an enzyme or receptor. While its proteins (e.g., E2, E7, or especially the capsid protein L1) can be considered molecular targets for diagnostics or vaccine development, the whole virus itself is not typically classified as a therapeutic target in drug discovery frameworks[4].

Other names

HPV-6HPV type 6Human papillomavirus 6

For vaccines: Induction of neutralizing antibodies against the L1 capsid protein to prevent infection[3].